Min Feng
- Topics
- Nanoplatforms for cancer theranostics (5 papers)Cancer Immunotherapy and Biomarkers (4 papers)Peptidase Inhibition and Analysis (3 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Min Feng
28 papers receiving 797 citations
Peers
Comparison fields: 5 of 97
- Molecular Biology 251
- Oncology 240
- Immunology 177
- Cancer Research 140
- Epidemiology 138
Countries citing papers authored by Min Feng
This map shows the geographic impact of Min Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Feng more than expected).
Fields of papers citing papers by Min Feng
This network shows the impact of papers produced by Min Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Feng. The network helps show where Min Feng may publish in the future.
Co-authorship network of co-authors of Min Feng
This figure shows the co-authorship network connecting the top 25 collaborators of Min Feng. A scholar is included among the top collaborators of Min Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min Feng. Min Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 5 | |
| 6 | 12 | |
| 7 | 69 | |
| 8 | 81 | |
| 9 | 17 | |
| 10 | 37 | |
| 11 | High expression of Rap2A is associated with poor prognosis of patients with hepatocellular carcinoma. | 11 |
| 12 | 50 | |
| 13 | 45 | |
| 14 | 57 | |
| 15 | 22 | |
| 16 | 17 | |
| 17 | 4 | |
| 18 | 38 | |
| 19 | 31 | |
| 20 | 4 |
About Min Feng
Min Feng is a scholar working on Geriatrics and Gerontology, Biological Psychiatry and Hepatology, having authored 31 papers that have together received 803 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Geriatrics and Gerontology (74 citations), Cancer Research (140 citations) and Hepatology (71 citations). Min Feng has collaborated with scholars based in China and United States. Frequent co-authors include Wenxian Guan, Song Liu, Wenxian Guan, Jun Feng, Peng-Fei Yan, Hongyang Zhao, Fangcheng Zhang, Feng Sun, Jie Ding and Jie Zhang. Their work appears in journals such as Scientific Reports, Journal of Controlled Release and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.